Cargando…
DDX41 is needed for pre- and postnatal hematopoietic stem cell differentiation in mice
DDX41 is a tumor suppressor frequently mutated in human myeloid neoplasms, but whether it affects hematopoiesis is unknown. Using a knockout mouse, we demonstrate that DDX41 is required for mouse hematopoietic stem and progenitor cell (HSPC) survival and differentiation, particularly of myeloid line...
Autores principales: | Ma, Jing, Mahmud, Nadim, Bosland, Maarten C., Ross, Susan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023775/ https://www.ncbi.nlm.nih.gov/pubmed/35303436 http://dx.doi.org/10.1016/j.stemcr.2022.02.010 |
Ejemplares similares
-
DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation
por: Rolles, Benjamin, et al.
Publicado: (2023) -
DDX41-associated susceptibility to myeloid neoplasms
por: Makishima, Hideki, et al.
Publicado: (2023) -
DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cells
por: Shinriki, Satoru, et al.
Publicado: (2022) -
The emerging roles of the DDX41 protein in immunity and diseases
por: Jiang, Yan, et al.
Publicado: (2016) -
Current Understanding of DDX41 Mutations in Myeloid Neoplasms
por: Kim, Kunhwa, et al.
Publicado: (2023)